News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tommasi Ruben
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 22,816 options to buy
@ $4.98, valued at
$113.6k
Granted 15,210 options to buy
@ $2.44, valued at
$37.1k
Disposed/sold 15,632 options to buy
@ $6.85, valued at
$107.1k
Granted 12,024 options to buy
@ $2.44, valued at
$29.3k
Disposed/sold 50,411 options to buy
@ $15, valued at
$756.2k
Granted 28,006 options to buy
@ $2.44, valued at
$68.3k
Disposed/sold 56,500 options to buy
@ $5.66, valued at
$319.8k
Granted 43,460 options to buy
@ $2.44, valued at
$106k
|
|
| 01/19/2022 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 11/03/2021 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Paid exercise price by delivering 3,669 shares
@ $2.94, valued at
$10.8k
|
|
| 10/20/2021 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 25,000 shares
@ $0
Sold 3,759 shares
@ $3.19, valued at
$12k
|
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.94, valued at
$247k
|
|
| 01/22/2019 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 56,500 options to buy
@ $5.66, valued at
$319.8k
|
|
| 12/26/2018 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Exercised 11,788 options to buy
@ $3.74, valued at
$44.1k
Exercised 10,236 options to buy
@ $3.11, valued at
$31.8k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Tommasi Rubin (Chief Science Officer) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
|
|